Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: A systematic review and meta-analysis

Molecular Biology Reports

Volumn 39, Issue 8, 2012, Pages 8551-8558

  Cui, Wenpeng ^a   Du, Bing ^a   Zhou, Wenhua ^a   Jia, Ye ^a   Sun, Guangdong ^a   Sun, Jing ^a   Zhang, Dongmei ^a   Yuan, Hang ^a   Xu, Feng ^a   Lu, Xuehong ^a   Luo, Ping ^a   Miao, Lining ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Gene polymorphism; Glucose transporter 1; Meta analysis; Single nucleotide polymorphism

Indexed keywords

CAUCASIAN; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLUT1 GENE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; PUBLISHING;

GLUCOSE TRANSPORTER 1;

ALLELES; DIABETIC NEPHROPATHIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84868666639     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1711-z     Document Type: Review

References (48)

1. Gross JL, de Azevedo MJ, Silveiro SP, et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164-176
2. Zhang P, Zhang X, Brown J, et al. (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:293-301
3. De Cosmo S, Prudente S, Lamacchia O, et al. (2011) PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies. Nephrol Dial Transplant 26:4011-4016
4. He Y, Fan Z, Zhang J, et al. (2011) Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26:339-349
5. Cui WP, Du B, Jia Y, et al. (2012) Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in Chinese population? Arch Med Res 43:42-50
6. Manolescu AR, Witkowska K, Kinnaird A, et al. (2007) Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 22:234-240
7. Baldwin SA, Lienhard GE (1989) Purification and reconstitution of glucose transporter from human erythrocytes. Methods Enzymol 174:39-50
8. Heilig C, Zaloga C, Lee M, et al. (1995) Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Lab Invest 73:674-684
9. Heilig CW, Liu Y, England RL, et al. (1997) d-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications of diabetic nephropathy. Diabetes 46:1030-1039
10. Brosius FC, Heilg CW (2005) Glucose transporters in diabetic nephropathy. Pediatr Nephrol 20:447-451
11. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15:55-57
12. Wang Y, Heilig KO, Minto AW, et al. (2010) Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF. Lab Invest 90:83-97
13. Studer RK, Craven PA, DeRubertis FR (1993) Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118-126
14. Pfäfflin A, Brodbeck K, Heilig CW, et al. (2006) Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1alpha. Cell Physiol Biochem 18:199-210
15. Heilig CW, Kreisberg JI, Freytag S, et al. (2001) Antisense GLUT1 protects mesangial cells from glucose induction of GLUT1 and fibronectin. Am J Physiol Renal Physiol 280:F657-F666
16. Hsu CC, Kao WL, Steffes MW, et al. (2011) Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis risk in Communities (ARIC) study. BMC Med Genet 12:16-28
17. Stefanidis I, Kytoudis K, Papathanasiou AA, et al. (2009) XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers 27:29-35
18. Makni K, Jarraya F, Rebaï M, et al. (2008) Risk genotypes and haplotypes of the GLUT1 gene for type 2 diabetic nephropathy in the Tunisian population. Ann Hum Biol 35:490-498
19. Hodgkinson AD, Page T, Millward BA, et al. (2005) A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. J Diabetes Complicat 19:65-69
20. Ng DP, Canani L, Araki S, et al. (2002) Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264-2269
21. Hodgkinson AD, Millward BA, Demaine AG (2001) Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy. Kidney Int 59:985-989
22. Tarnow L, Grarup N, Hansen T, et al. (2001) Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 16:1653-1656
23. Liu ZH, Guan TJ, Chen ZH, et al. (1999) Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843-1848
24. Gutierrez C, Vendrell J, Pastor R, et al. (1998) GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 41:113-120
25. Grzeszczak W, Moczulski DK, Zychma M, et al. (2001) Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. Kidney Int 59:631-636
26. Lau J, Ioannidis JP, Schmid CH (1998) Summing up evidence: one answer is not always enough. Lancet 351:570-573
27. Lau J, Ioannidis JP, Schmid CH (1997) Qauntitative synthesis in systematic reviews. Ann Intern Med 127:820-826
28. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672-3673
29. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
30. Harel Z, Gilbert C, Wald R, et al. (2012) The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ [Epub ahead of print]
31. Leucht S, Corves C, Arbter D, et al. (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31-41
32. Wang Y, Chen J, Wang Y, et al. (2011) A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant 26:1923-1931
33. Mueckler M, Caruso C, Baldwin SA, et al. (1985) Sequence and structure of a human glucose transporter. Science 229:941-945
34. Hruz PW, Mueckler MM (2001) Structural analysis of the GLUT1 facilitative glucose transporter (review). Mol Membr Biol 18:183-193
35. Arnoni CP, Lima C, Cristovam PC, et al. (2009) Regulation of glucose uptake in mesangial cells stimulated by high glucose: role of angiotensin II and insulin. Exp Biol Med (Maywood) 234:1095-1101
36. Sokolovska J, Isajevs S, Sugoka O, et al. (2010) Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model. Arch Physiol Biochem 116:137-145
37. Heilig CW, Concepcion LA, Riser BL, et al. (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814
38. Wang Y, Heilig K, Saunders T, et al. (2010) Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Am J Physiol Renal Physiol 299:99-111
39. Tao T, Tanizawa Y, Matsutani A, et al. (1995) HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia 38:942-947
40. Baroni MG, D'Andrea MP, Capici F, et al. (1998) High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis. Hum Genet 102:479-482
41. Lefrançois-Martinez AM, Martinez A, Antoine B, et al. (1995) Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 270:2640-2643
42. Gosek K, Moczulski D, Zukowska-Szczechowska E, et al. (2005) C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycemic control. Nephron Exp Nephrol 99:63-67
43. Sivenius K, Niskanen L, Voutilainen-Kaunisto R, et al. (2004) Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes. Diabet Med 21:1325-1533
44. Zhao HL, Tong PC, Lai FM, et al. (2004) Association of glomerulopathy with the 5′-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. Diabetes 53:2984-2991
45. Costa GC, Alcantara LC, Azevedo R, et al. (2010) Frequency distribution of XbaIG > T and HaeIII T > C GLUT1 polymorphisms among different Brazilian ethnic groups. Mol Biol Rep 37:75-79
46. Li SR, Oelbaum RS, Bouloux PM, et al. (1990) Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasian and west Indian subjects with non-insulin-dependent diabetes mellitus. Hum Hered 40:38-44
47. Zintzaras E, Stefanidis I (2005) Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50:84-91
48. Mooyaart AL, Valk EJ, van Es LA, et al. (2011) Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 54:544-553